Key result
Blocking periostin isoforms with antisense oligonucleotides and antibodies markedly reduced osteoblast-specific-differentiation markers, suggesting a role in osteoblast differentiation.
Why the study?
Does blocking periostin isoforms reduce osteoblast differentiation in MC3T3-E1 cells?
Does blocking periostin isoforms reduce osteoblast differentiation in MC3T3-E1 cells?
Periostin isoforms, including periostin-like-factor (PLF), play a role in osteoblast differentiation.
No takes yet. Share an insight, caveat, or question.
Periostin blockade should not yet alter clinical bone therapies; leaves open its regulatory role pending in vivo and human validation.
Litvin et al. (2004) studied this question. Antisense oligonucleotides and antibodies directed against periostin isoforms was evaluated on Levels of osteoblast-specific-differentiation markers. Blocking periostin isoforms with antisense oligonucleotides and antibodies markedly reduced osteoblast-specific-differentiation markers, suggesting a role in osteoblast differentiation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: